Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by extensive fibrotic changes in various organs, including skin and lung. Although the etiology of SSc remains unknown, three major abnormalities, abnormal humoral immunity, microvasculature, and fibroblast dysfunctions are considered to play important roles. Significant progress has been made in understanding the pathogenesis on SSc, and has been also providing clues to the treatment for this disease. This review summarizes recent advances on the pathogenesis and new therapeutic strategy for SSc.
Recent advances on pathogenesis and therapies in systemic sclerosis. Publishing Authors By Initials
Recent advances on pathogenesis and therapies in systemic sclerosis. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Clinical reviews in allergy & immunology
VOLUME: 33
Page Numbers: 107-12
Journal Abbreviation:
ISSN: 1080-0549
DAY: 20
MONTH: Oct
YEAR: 2007
Recent advances on pathogenesis and therapies in systemic sclerosis. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9504368
Recent advances on pathogenesis and therapies in systemic sclerosis. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Recent advances on pathogenesis and therapies in systemic sclerosis. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Recent advances on pathogenesis and therapies in systemic sclerosis.
AFFILIATION: Department of Dermatology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan, yazawa-DER@h.u-tokyo.ac.jp.
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Clin Rev Allergy Immunol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Recent advances on pathogenesis and therapies in systemic sclerosis Related Publications